- Stocks
- Pharma & Healthcare
- Yatharth Hospital & Trauma Care Services
Yatharth Hospital & Trauma Care Services share price
NSE: YATHARTHPharma & HealthcareMedical Care Facilities
Yatharth Hospital & Trauma Care Services at a glance
Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) closed at ₹968.00 on 19 Oct 2026, down 2.52% on the day. With a market capitalisation of ₹9,327 Cr, it ranks 578th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
At its last close the stock traded at 53.1× trailing earnings, against a return on equity of 9.7% in FY26. Over the past year the share price has risen 19.5%. Its 52-week range is ₹538.25 (27 Jan 2026) to ₹1,184.00 (18 Sep 2026); the last close is 18.2% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹342 Cr (+47.4% year on year) and net profit ₹45 Cr (+15.4%), on a consolidated basis. Promoters held 55.80% of the company as of 30 Jun 2026; 9.59% of promoter shares were pledged.
Key numbers
- Market cap
- ₹9,327 CrRank 578 on NSE
- P/E (trailing)
- 53.1×
- Price to book
- 3.29×FY26
- EPS (TTM)
- ₹18.28to Q4 FY26
- ROE
- 9.7%FY26
- ROCE
- 11.0%FY26
- Debt to equity
- 0.14FY26
- Net profit margin
- 14.1%FY26
- Book value / share
- ₹187.55FY26
- 52-week high
- ₹1,184.0018 Sep 2026
- 52-week low
- ₹538.2527 Jan 2026
- 1-year return
- +19.5%
- RSI (14-day)
- 41.2
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −2.52% | −2.5% | −10.1% | +13.5% | +19.5% |
Yatharth Hospital & Trauma Care Services quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹212 Cr | ₹218 Cr | ₹219 Cr | ₹232 Cr | ₹258 Cr | ₹279 Cr | ₹320 Cr | ₹342 Cr |
| Revenue YoY | +37.1% | +27.1% | +31.4% | +30.4% | +21.7% | +28.3% | +46.2% | +47.4% |
| Net profit | ₹30 Cr | ₹31 Cr | ₹30 Cr | ₹39 Cr | ₹42 Cr | ₹41 Cr | ₹43 Cr | ₹45 Cr |
| Net profit YoY | +59.6% | +12.1% | +3.4% | +1.0% | +38.4% | +33.3% | +41.3% | +15.4% |
| Net margin | 14.3% | 14.2% | 13.9% | 16.7% | 16.3% | 14.8% | 13.4% | 13.1% |
| EPS | ₹3.54 | ₹3.59 | ₹3.57 | ₹4.37 | ₹4.36 | ₹4.28 | ₹4.71 | ₹4.93 |
Yatharth Hospital & Trauma Care Services financials
| Item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹520 Cr | ₹671 Cr | ₹880 Cr | — |
| Operating profit | ₹88 Cr | ₹157 Cr | ₹172 Cr | — |
| Net profit | ₹66 Cr | ₹114 Cr | ₹131 Cr | — |
| EPS (₹) | ₹10.00 | ₹14.00 | ₹15.00 | — |
| Cash from operations | ₹64 Cr | −₹3 Cr | ₹150 Cr | — |
| Total debt | ₹201 Cr | ₹75 Cr | ₹1 Cr | ₹227 Cr |
| Shareholders' equity | ₹183 Cr | ₹874 Cr | ₹1,606 Cr | ₹1,807 Cr |
Yatharth Hospital & Trauma Care Services shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 61.64% | 61.64% | 61.64% | 55.80% | 55.80% | 55.80% |
| Foreign institutions | 4.45% | 4.34% | 6.50% | 6.18% | 5.25% | 5.62% |
| Domestic institutions | 13.56% | 13.52% | 8.70% | 11.01% | 12.00% | 10.84% |
| Non-institutions | 20.35% | 20.50% | 23.16% | 27.01% | 26.95% | 27.74% |
| Promoter shares pledged | 13.81% | 13.81% | 15.33% | 10.73% | 10.73% | 9.59% |
Yatharth Hospital & Trauma Care Services vs peers
The listed Pharma & Healthcare companies nearest to Yatharth Hospital & Trauma Care Services by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| METROPOLISMetropolis Healthcare | ₹512.60 | −6.78% | +2.8% | ₹10,628 Cr | 55.8 | — |
| PARKHOSPSPark Medi World | ₹228.50 | −3.18% | — | ₹9,870 Cr | 33.3 | — |
| VIYASHViyash Scientific | ₹220.83 | −2.29% | +2.4% | ₹9,648 Cr | 55.1 | — |
| BLUEJETBlue Jet Healthcare | ₹508.00 | −2.50% | −25.0% | ₹9,615 Cr | 35.5 | — |
| STARStrides Pharma Science | ₹1,019.90 | −2.32% | +20.3% | ₹9,401 Cr | 16.9 | — |
| YATHARTHYatharth Hospital & Trauma Care Services | ₹968.00 | −2.52% | +19.5% | ₹9,327 Cr | 53.1 | — |
| HCGHealthcare Global Enterprises | ₹570.00 | −3.39% | −16.4% | ₹8,510 Cr | — | — |
Ask anything about Yatharth Hospital & Trauma Care Services
Pivot answers on the live chart with evidence you can check, and tests strategies against YATHARTH's own history. Try: “Why has YATHARTH moved over the last three months?” · “Backtest a 50-day moving-average crossover on YATHARTH over five years” · “Compare YATHARTH with METROPOLIS on margins and valuation”
Frequently asked questions about Yatharth Hospital & Trauma Care Services
What is the share price of Yatharth Hospital & Trauma Care Services today?
Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) last closed at ₹968.00 on 19 Oct 2026. Its 52-week high is ₹1,184.00 and its 52-week low is ₹538.25.
What is the market cap of Yatharth Hospital & Trauma Care Services?
Yatharth Hospital & Trauma Care Services' market capitalisation is ₹9,327 Cr (₹9,327 Cr) at the 19 Oct 2026 close, ranking 578th among the NSE companies Pivot tracks.
What is the P/E ratio of Yatharth Hospital & Trauma Care Services?
Yatharth Hospital & Trauma Care Services trades at a trailing P/E of 53.1. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 35.5.
What is the ROE and ROCE of Yatharth Hospital & Trauma Care Services?
Return on equity was 9.7% in FY26 and return on capital employed was 11.0% in FY26 (consolidated figures).
Is Yatharth Hospital & Trauma Care Services a debt-free company?
No. Yatharth Hospital & Trauma Care Services' debt-to-equity ratio was 0.14 in FY26, with total debt of ₹227 Cr.
What were Yatharth Hospital & Trauma Care Services' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Yatharth Hospital & Trauma Care Services reported revenue of ₹342 Cr, +47.4% year on year, and net profit of ₹45 Cr, +15.4% year on year.
How has Yatharth Hospital & Trauma Care Services stock performed over the last year?
Yatharth Hospital & Trauma Care Services' share price has risen 19.5% over the past year, +13.5% over three months and −10.1% over one month, to the 19 Oct 2026 close.
What is the shareholding pattern of Yatharth Hospital & Trauma Care Services?
As of 30 Jun 2026: promoters 55.80%, foreign institutions 5.62%, domestic institutions 10.84%, non-institutions 27.74%. 9.59% of promoter shares were pledged.
Who are Yatharth Hospital & Trauma Care Services' competitors?
The listed Pharma & Healthcare companies closest to Yatharth Hospital & Trauma Care Services by market cap are Metropolis Healthcare, Park Medi World, Viyash Scientific, Blue Jet Healthcare, Strides Pharma Science and Healthcare Global Enterprises.
Is Yatharth Hospital & Trauma Care Services a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Yatharth Hospital & Trauma Care Services' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on YATHARTH against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with Y · all NSE stocks · this page as text